ginkgolide b has been researched along with Alzheimer Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Gao, Y; Li, S; Yang, G; Yu, D; Zhang, J; Zhang, Y; Zhao, Y | 1 |
| Dong, C; Geng, D; He, Q; Shao, L; Shi, Y | 1 |
| Cai, X; Chen, W; Lu, C; Yang, P; Zhou, K | 1 |
| Hou, Q; Li, J; Ma, J; Wang, C; Wang, W; Wang, Z; Xiao, Q | 1 |
| Ahlemeyer, B; Krieglstein, J | 1 |
| Chen, CF; Lee, TF; Wang, LC | 1 |
| Bastianetto, S; Quirion, R; Zheng, WH | 1 |
1 review(s) available for ginkgolide b and Alzheimer Disease
| Article | Year |
|---|---|
Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Apoptosis; Brain Ischemia; Cells, Cultured; Cyclopentanes; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Flavones; Flavonoids; Furans; Ginkgo biloba; Ginkgolides; Glutamic Acid; Humans; Hypoxia; Lactones; Neurons; Neuroprotective Agents; Plant Extracts; Time Factors | 2003 |
6 other study(ies) available for ginkgolide b and Alzheimer Disease
| Article | Year |
|---|---|
Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Ginkgolides; Humans; Inflammasomes; Lactones; Mice; Microglia; Neuroinflammatory Diseases; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments | 2021 |
Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Autophagy; Ginkgolides; Inflammasomes; Lactones; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein | 2022 |
A novel oil-body nanoemulsion formulation of ginkgolide B: pharmacokinetics study and in vivo pharmacodynamics evaluations.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Choline O-Acetyltransferase; Emulsions; Ginkgolides; Hippocampus; Lactones; Memory; Pharmaceutical Vehicles; Rats; Rats, Sprague-Dawley | 2014 |
Ginkgolide B protects hippocampal neurons from apoptosis induced by beta-amyloid 25-35 partly via up-regulation of brain-derived neurotrophic factor.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Caspase 3; Cells, Cultured; Female; Fibrinolytic Agents; Fluorescent Dyes; Ginkgolides; Hippocampus; Lactones; Nerve Growth Factors; Neurons; Peptide Fragments; Rats; Rats, Sprague-Dawley; Up-Regulation | 2010 |
Effect of ginkgolides on beta-amyloid-suppressed acetylocholine release from rat hippocampal slices.
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Diterpenes; Dose-Response Relationship, Drug; Ginkgo biloba; Ginkgolides; Hippocampus; Lactones; Male; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley | 2004 |
The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C.
Topics: Alkaloids; Alzheimer Disease; Animals; Antioxidants; Azoles; Benzophenanthridines; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Diterpenes; Enzyme Inhibitors; Estrenes; Flavonoids; Free Radical Scavengers; Ginkgo biloba; Ginkgolides; Hippocampus; Isoindoles; Lactones; Molsidomine; Neurons; Neuroprotective Agents; Nitrendipine; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Organoselenium Compounds; Oxidative Stress; Phenanthridines; Phosphodiesterase Inhibitors; Plant Extracts; Plants, Medicinal; Protein Kinase C; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasodilator Agents | 2000 |